Unlocking Innovation: AI for IP Support & Docketing Specialists
May 20, 2026 1:00 PM to 2:30 PM
The AIPLA Special Committee on IP Support Specialists and the NDA IP Chapter present: Unlocking Innovation: AI for IP Support & Docketing Specialists
Speaker: Ann McCrackin, AI-Enabled Attorney, LLC
AI is changing everyday legal work, including the work of IP support and docketing teams. Building on Ann McCrackin’s highly rated 2025 NDA Conference presentation, this program will show how NotebookLM can help teams work with a defined set of source materials. It will also introduce custom GPTs as a way to create repeatable assistants for recurring IP support tasks. In addition, it will cover important guardrails, including using firm-approved business or enterprise AI tools for client-related work and verifying AI-generated output before relying on it. Attendees will leave with practical examples of how AI can support efficiency, accuracy, and evolving IP operations.
Speakers
-
McCrackin, Ann
AI-Enabled Attorney, LLC | Founder
Ann McCrackin is a patent attorney, Adjunct Professor at the University of New Hampshire Franklin Pierce School of Law, and founder of AI-Enabled Attorney LLC. She provides practical AI training and IP operations consulting for law firms and legal teams, with a focus on helping professionals use AI effectively in real patent and trademark workflows.
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.